Biological organism for preparing pharmaceutical compositions for treating mammals
CA 2435949 A1 · Owner: Paul, Stephane · Inventors: Paul, Stephane; Regulier, Etienne
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns a biological organism comprising at least: (i) a nucleic acid coding for all or part of an antibody said antibody being expressed at the surface of a host cell and capable of being fixed to a polypeptide present at the surface of a cytotoxic effector cell or of a T-helper lymphocyte and involved in the process of activating such a cell and (ii) a nucleic acid coding for all or part of a polypeptide involved in the stimulation of an immune response or in attraction to the site of expression and activation of cytotoxic effector cells or of T-helper lymphocytes said polypeptide being selected among chemokines and co-stimulation molecules. The invention also concerns a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 28, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 28, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 28, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.